CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Return
4.23%
This Quarter Return
+6.25%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.86B
AUM Growth
-$147K
(-0.01%)
Cap. Flow
-$293M
Cap. Flow
% of AUM
-10.24%
Top 10 Holdings %
Top 10 Hldgs %
64.87%
Holding
43
New
5
Increased
6
Reduced
7
Closed
7
Top Buys
| 1 |
Biogen
BIIB
|
$86.3M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$57.2M |
| 3 |
Denali Therapeutics
DNLI
|
$30.8M |
| 4 |
Qiagen
QGEN
|
$26.4M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$21.8M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$194M |
| 2 |
Universal Health Services
UHS
|
$113M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$43.8M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$43M |
| 5 |
QuidelOrtho
QDEL
|
$29.5M |
Sector Composition
| 1 | Healthcare | 96.94% |
| 2 | Consumer Staples | 1.6% |
| 3 | Consumer Discretionary | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
BioMarin Pharmaceuticals
BMRN
$11.1B
| $21.8M | 0.54% |
+250,000
| New | +$21.8M |
|
27
Peloton Interactive
PTON
$3.27B
| $19.3M | 0.47% |
4,500,000
| – | – |
|
28
Inogen
INGN
$219M
| $16.1M | 0.4% |
2,000,000
| – | – |
|
29
The Beauty Health Co
SKIN
$260M
| $15.5M | 0.38% |
3,500,000
| – | – |
|
|
BCYC
30
Bicycle Therapeutics
BCYC
$496M
| $11.2M | 0.27% |
450,000
| – | – |
|
31
Theravance Biopharma
TBPH
$703M
| $8.97M | 0.22% |
+1,000,000
| New | +$8.97M |
|
32
Puma Biotechnology
PBYI
$253M
| $8.75M | 0.21% |
1,650,000
-1,155,000
| -41% | -$6.12M |
|
33
CureVac
CVAC
$1.21B
| $5.3M | 0.13% |
1,750,000
| – | – |
|
34
Genmab
GMAB
$16.9B
| $1.5M | 0.04% |
+50,000
| New | +$1.5M |
|
35
Ascendis Pharma
ASND
$12.5B
| – | – |
-165,000
| Closed | -$20.8M |
|
36
Harmony Biosciences
HRMY
$2.07B
| – | – |
-750,000
| Closed | -$24.2M |
|
|
37
Ionis Pharmaceuticals
IONS
$9.76B
| – | – |
-865,000
| Closed | -$43.8M |
|
38
Moderna
MRNA
$9.78B
| – | – |
-250,000
| Closed | -$24.9M |
|
39
Pfizer
PFE
$141B
| – | – |
0
| – | – |
|
|
40
QuidelOrtho
QDEL
$1.95B
| – | – |
-400,000
| Closed | -$29.5M |
|
|
41
Ultragenyx Pharmaceutical
RARE
$3.07B
| – | – |
-900,000
| Closed | -$43M |
|
42
Solid Biosciences
SLDB
$428M
| – | – |
-1,418,439
| Closed | -$8.71M |
|
43
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|